Cervicitis is a common clinical finding often attributed to sexually transmitted infections (STIs), 30 but no etiologic agent is identified in the majority of cases. In this study, we comparatively assessed 31 inflammation among the common infectious etiologies of cervicitis and assessed the potential value of 32 liquid cytology specimens for predicting STIs. Among 473 Louisiana women at low risk for acquiring 33
INTRODUCTION 54
Inflammation of the uterine cervix, termed cervicitis, is characterized clinically by the presence 55 of either mucopurulent discharge from the cervical os and/or easily-induced bleeding after endocervical 56 sampling (cervical friability). Cervicitis appears to be a very common clinical finding [1] , and has in fact 57 been coined "the ignored counterpart in women of urethritis in men" [2] . Classically, cervicitis has been 58 managed "syndromically" by treating the most likely etiologic agents prior to an accurate diagnosis. 59
This is a common practice in STD clinics to manage lower urogenital inflammation in men and women 60 because it is imperative to initiate therapy before STI test results are available. CDC guidelines 61 recommend such empiric therapy of cervicitis in patients suspected to have C. trachomatis or N. 62 gonorrhoeae -particularly in populations with high STI prevalence [3] . Although no etiologic agent is 63 identified in the majority of cases, the most common infectious causes of cervicitis are Chlamydia 64 trachomatis and Neisseria gonorrhoeae [2, 4] followed less commonly by Mycoplasma genitalium, 65
Trichomonas vaginalis, and Herpes Simplex Virus types I and II [5]. 66
A diagnosis of cervicitis currently relies upon direct observation of the aforementioned clinical 67 signs during pelvic exam. Unfortunately, algorithms for syndromic management of STIs have proven to 68 be largely ineffective when using vaginal signs to predict cervical infection, which can be detected by 69 less invasive methods [5] . Some specialists continue to utilize microscopic signs of cervicitis (elevated 70 number of polymorphonuclear leukocytes per high-powered microscope field; PMNL/HPF) observed on 71 endocervical gram stains as presumptive evidence for treatment of STIs despite conflicting data on 72 usefulness and being removed from the CDC treatment guidelines in 1993 [6] . Over time, the threshold 73 genitalium is comparatively sparse, but a 2013 study showed that endocervical gram stains have 79 similarly poor utility [10] . Collectively, endocervical gram stains appear to have limited usefulness as a 80 point of care (POC) procedure for predicting the most commonly identified etiologies of cervicitis. With 81 the assumption that cervicitis is an important pathological condition, either as an independent syndrome 82 or an identifiable risk factor for upper tract disease, a clear need exists to enhance the POC management 83 of STIs in this context. 84 M. genitalium is a prevalent and emerging STI linked epidemiologically to pelvic inflammatory 85 disease, tubal-factor infertility and cervicitis (Reviewed in [11, 12] ). Despite solid evidence as a cause of 86 male non-gonococcal urethritis (NGU), additional studies are needed to unequivocally implicate M. 87 genitalium as a cause of cervicitis and other female reproductive tract syndromes. M. genitalium has a 88 remarkable ability to establish chronic infections of the lower genital tract [13] [14] [15] [16] System (Bio-Rad Laboratories, Inc.) with two-step cycling parameters as described previously [30] . 134
Samples with a positive result using the MG190 TaqMan PCR assay were confirmed using a PCR assay 135 targeting a conserved region of mgpB using primers 1F and 1R [16] with SYBR Green detection 136 chemistry. Melt curve analysis was used to confirm amplicon specificity. 137 C. trachomatis testing was performed using a real-time qPCR assay targeting the cryptic plasmid 138 as described previously [31] . N. gonorrhoeae testing was performed using a SYBR Green qPCR assay 139 
Cervical Leukocyte Quantification 154
Approximately 100 uL of each ThinPrep PreservCyt specimen was placed onto a glass 155 microscope slide, air-dried for 15 min at room temperature, and then stained with Diff-Quik reagents per 156 the manufacturer's instructions (Siemens Healthcare Diagnostics, Ltd., Deerfield, IL). Leukocytes and 157 epithelial cells were quantified in parallel from 5 representative high-powered fields by an ASCP-158 certified cytologist; cell counts were entered into a customized requisition form. First, all subjects mono-159 positive for M. genitalium (n=5) and a randomly selected subset of subjects negative for all tested STIs 160 (n=40) were stained for evaluation of M. genitalium-specific modulation of cervical leukocyte counts. 161
Next, all specimens testing positive for mono-infections of C. trachomatis (n=9), N. gonorrhoeae (n=2), 162
and T. vaginalis (n=18) were processed for comparison to M. genitalium-positive subjects and those 163 testing negative for all STIs. The prevalence of each STI, stratified by variable thresholds of 164 leukocyte/epithelial cell ratios (2 or 2.5), was used to calculate PPVs (Table 2 ). In order to eliminate 165 experimental bias, the cytologist was masked to the NAAT results throughout the study. 166
M. genitalium Genotyping 167
DNA specimens from subjects with positive results from both the MG190 TaqMan 
Statistical Analysis 183
The ANOVA was used to determine whether STIs were associated significantly with increased 184 ratios of cervical leukocytes to epithelial cells whereby significant differences were noted when p<0.05. 185
Compiled contingency tables and calculated odd ratios (OR) were used for univariate analysis of the 186 associations between M. genitalium infection and other STIs. The Fisher's Exact test was used to 187 determine whether significant associations exist, and P values are reported in Table 1 . Similarly, 188 contingency tables were assembled to determine the PPV of variable leukocyte/epithelial cell ratios 189 among STIs, followed by the Fisher's exact test (Table 2) . PPV was calculated using Prism (Version 6; 190
GraphPad Software, Inc., La Jolla, CA). 191
192

RESULTS
193
Performance of the M. genitalium diagnostic PCR system 194 The MG190 TaqMan PCR assay was described previously [30] . In the current study, we 195 evaluated performance of the MG191 assay with liquid cytology specimens. Reproducibility of M. 196 genitalium detection was determined by measuring inter-assay precision among 10 independent PCR 197 runs. Liquid cytology specimens spiked with serial dilutions of M. genitalium G37 organisms showed a 198 linear range of detection from 1x10 4 to 3x10 7 organisms per mL with % coefficient of variations ranging 199 from 1.3 to 2.7 (Fig. 1A) . The reproducible limit of detection (LOD), was 3x10 4 organisms per mL, 200 which was detected in 100% of reactions. Concentrations of 1x10 4 organisms per mL were detected in 201 60% of specimens ( ± 0.5; n=18) infections also showed increased leukocyte/epithelial cell ratios, but these increases were 237 not significantly different than subjects with no detectable STIs (p>0.05, ANOVA). 238
The PPV of measuring leukocyte/epithelial cell ratios from stained smears of liquid cytology 239 specimens ranged from 20 to 100% among STIs using a threshold of positivity of >2.0 240 leukocytes/epithelial cell/HPF ( Table 2) . As expected, the PPV decreased if the threshold was raised to 241 the more stringent cutoff of >2.5 leukocytes/epithelial cell/HPF. Using either threshold of positivity, the 242 prevalence of M. genitalium or C. trachomatis infection was significantly higher in subjects with these 243 inflammatory signs compared to those without signs. Similar trends were not observed for subjects with 244 N. gonorrhoeae or T. vaginalis infections (Table 2) . 245 to be 100% identical to a previously defined strain (M6283; Miyazaki, Japan). The remaining six 253 genotypes had unique MG191 sequences differing from all previously published sequences in the NCBI 254 database, as well as among each other (Fig. 3) . These nucleotide sequences have been submitted to 255 NCBI with accession numbers KF995739-KF995744. 256
257
DISCUSSION 258
In this study, approximately 1 in 65 women presenting to women's clinics in Louisiana for 259 cervical cancer screening tested positive for M. genitalium infection (1.5%). As expected, this 260 prevalence was in between that of N. gonorrhoeae (0.6%) and C. trachomatis (2.1%), and substantially 261 lower than previous observations of high-risk subjects that include STD clinic attendees, subjects 262 attending family planning clinics for termination of pregnancy, or commercial sex workers [11] . On 263 average, urogenital M. genitalium infection occur in approximately 2% of low-risk women recruited 264 from fertility clinics, otherwise healthy subjects enrolled in population-based studies, or subjects 265 enrolled in studies of adverse pregnancy outcomes [11] . In a study by Manhart and colleagues, 1.3% of 266 otherwise healthy young adults aged 18-27 in the southern region of the USA tested positive for M. 267 genitalium infection [43] . Our observed prevalence of 1.5% from Louisiana women's clinics was on par 268 with these studies, however, women enrolled in our study were older (median age = 42) and samples 269 were obtained during routine cervical cancer screening visits to either rural or urban women's clinics. 270
The finding that M. genitalium is more common than N. gonorrhoeae and similar to C. trachomatis in 271 this population highlights the potential need to screen older populations such as the case for T. vaginalis. 272
The convention of categorically defining cervicitis based on elevated levels of PMNL/HPF on 273 endocervical gram stains has prevented an accurate assessment of inflammation by distilling the findings 274 into a qualitative endpoint of cervicitis/no cervicitis. Perhaps even more troubling with this method is 275 the lack of an adequate control for sampling efficiency. Using liquid cytology specimens in the current 276 study, direct leukocyte quantification as a ratio to epithelial cells accounts for sampling efficiency and PPVs for other STIs should be interpreted with caution since the STI prevalence was very low. 291
Collectively, despite screening almost 500 low-risk women, expansion of the study to include high-risk 292 women and differing age groups is warranted to better understand the utility of this method for 293 predicting STIs. 294
Previous studies have shown that vaginal swabs may have a greater relative sensitivity for M. 295 genitalium detection than cervical swabs [45, 46] , and a combination of these sites yields a sensitivity of 296 more than 95% [45] . Liquid cytology specimens predominately contain squamous cells of the ectocervix 297 but because the anatomical target of sampling is the transition zone between the ecto-and endocervix, 298 columnar cells of the endocervix are also present. We routinely observed vaginal microflora suggesting 299 that this specimen type may be ideal for M. genitalium detection as it offers a composite sampling of the 300 lower urogenital tract. Regarding analytical sensitivity, the defined lower threshold of reproducible 301 detection was 3x10 4 organisms/mL of ThinPrep PreservCyt fluid and represents a potential limitation to 302 on August 15, 2017 by guest http://jcm.asm.org/ Downloaded from the current study. We hypothesize that this is due to the relatively small 5 L template used in the PCR 303 and that additional optimization of the system would likely enhance sensitivity. With this potential 304 limitation, it is possible that subjects with low M. genitalium titers were not detected, and therefore the 305 observed microscopic signs of inflammation are representative of subjects with high titers. Additionally, 306 several specimens identified as positive with the MG190 screening test were not confirmed with a 307 second test suggesting that specificity of the MG190 PCR is sub-par and should be enhanced to reduce 308 false-positive results. Additional investigation of this specimen type and detection system is warranted 309 considering the widespread use of liquid cytology specimens for cervical cancer screening and HPV 310 testing in women aged 21-65 [29] . 311
We identified six previously un-discovered genotypes all of which were susceptible to 312 macrolides suggesting that M. genitalium strains circulating in low-risk women may differ from those in 313 high-risk populations. This study, to our knowledge, is the first to investigate macrolide susceptibility 314 among low-risk women and suggests that M. genitalium strains circulating in this population are more 315 susceptible to these antibiotics compared to higher-risk populations whereby AZM is less effective [12, is the recommended and most commonly used antibiotic [12, 47] , but reports of resistance are emerging 323
This study highlights the importance of M. genitalium as an etiology of cervicitis and the 325 potential utility of liquid cytology specimens for diagnosis and measuring inflammation. The major 326 limitation to interpreting the significance of the findings is the low prevalence of M. genitalium andother STIs, and the inability to stratify our results by age. A larger cohort will be required to corroborate 328 the results in both high and low-risk populations, particularly with regard to the PPV of this method as a 329 POC procedure. Since the prevalence of STIs would be substantially higher in high-risk populations, our 330 findings may not be generalizable to these women since co-infections, frequent re-infection, BV, and 331 other factors may complicate the validity of measuring leukocyte/epithelial cell ratios. Importantly, 332 cervicitis has been associated with increased HIV shedding, and treatment of the condition reduces both 333 viral shedding and the presence of virus-infected cells in cervical secretions [51] [52] [53] M. genitalium G37 organisms were spiked into ThinPrep PreservCyt specimens at concentrations ranging from 1x10 4 -3x10 7 organisms / mL. DNA was purified from each spiked specimen and used as template in ten replicate PCR reactions run on separate plates. (B) In a separate study, after spiking M. genitalium G37 organisms at the indicated concentrations, five independent DNA purifications and PCRs were performed once weekly over a five week period to evaluate inter-assay precision of the assay system. Data are presented as cycle of quantification (Cq) with % coefficient of variation for each group. 
